Abstract
Lung cancer is the leading cause of deaths in cancer patients in the United States. Identification of new molecular targets is clearly needed to improve therapeutic outcomes of this devastating human disease. Activating mutations in K-Ras oncogene and increased expression of FOXM1 protein are associated with poor prognosis in patients with non-small-cell lung cancer. Transgenic expression of activated KrasG12D in mouse respiratory epithelium is sufficient to induce lung adenocarcinomas; however, transcriptional mechanisms regulated by K-Ras during the initiation of lung cancer remain poorly understood. Foxm1 transcription factor, a downstream target of K-Ras, stimulates cellular proliferation during embryogenesis, organ repair and tumor growth, but its role in tumor initiation is unknown. In the present study, we used transgenic mice expressing KrasG12D under control of Sftpc promoter to demonstrate that Foxm1 was induced in type II epithelial cells before the formation of lung tumors. Conditional deletion of Foxm1 from KrasG12D-expressing respiratory epithelium prevented the initiation of lung tumors in vivo. The loss of Foxm1 inhibited expression of K-Ras target genes critical for the nuclear factor-κB (NF-κB) and c-Jun N-terminal kinase (JNK) pathways, including Ikbkb, Nfkb1, Nfkb2, Rela, Jnk1, N-Myc, Pttg1 and Cdkn2a. Transgenic overexpression of activated FOXM1 mutant was sufficient to induce expression of these genes in alveolar type II cells. FOXM1 directly bound to promoter regions of Ikbkb, Nfkb2, N-Myc, Pttg1 and Cdkn2a, indicating that these genes are direct FOXM1 targets. FOXM1 is required for K-Ras-mediated lung tumorigenesis by activating genes critical for the NF-κB and JNK pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- Cre:
-
Cre recombinase
- Dox:
-
doxycycline
- Fox:
-
Forkhead Box transcription factor
- NF-κB:
-
nuclear factor-κB
- NSCLC:
-
non-small-cell lung cancer.
References
Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108.
Alberg AJ, Samet JM . Epidemiology of lung cancer. Chest 2003; 123: 21S–49S.
Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV et al. The forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006; 66: 2153–2161.
Costa RH, Kalinichenko VV, Major ML, Raychaudhuri P . New and unexpected: forkhead meets ARF. Curr Opin Genet Dev 2005; 15: 42–48.
Kalin TV, Ustiyan V, Kalinichenko VV . Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell cycle (Georgetown, Tex) 2011; 10: 396–405.
Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z . A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006; 38: 1043–1048.
Wang IC, Meliton L, Tretiakova M, Costa RH, Kalinichenko VV, Kalin TV . Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors. Oncogene 2008; 27: 4137–4149.
Wang IC, Meliton L, Ren X, Zhang Y, Balli D, Snyder J et al. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis. PLoS One 2009; 4: e6609.
Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 2001; 15: 3249–3262.
Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243–3248.
Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111–1116.
Major ML, Lepe R, Costa RH . Forkhead Box M1B (FoxM1B) transcriptional activity requires binding of Cdk/Cyclin complexes for phosphorylation-dependent recruitment of p300/cbp co-activators. Mol Cell Biol 2004; 24: 2649–2661.
Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, Yao KM . Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 2005; 118: 795–806.
Wang IC, Snyder J, Zhang Y, Lander J, Nakafuku Y, Lin J et al. Foxm1 mediates cross talk between Kras/mitogen-activated protein kinase and canonical Wnt pathways during development of respiratory epithelium. Mol Cell Biol 2012; 32: 3838–3850.
Behren A, Muhlen S, Acuna Sanhueza GA, Schwager C, Plinkert PK, Huber PE et al. Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion. Oncogene 2010; 29: 1519–1530.
Kalin TV, Wang IC, Meliton L, Zhang Y, Wert SE, Ren X et al. Forkhead Box m1 transcription factor is required for perinatal lung function. Proc Natl Acad Sci USA 2008; 105: 19330–19335.
Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, Ladd-Acosta C et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet 2005; 37: 48–55.
Watters JW, Roberts CJ . Developing gene expression signatures of pathway deregulation in tumors. Mol Cancer Ther 2006; 5: 2444–2449.
Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133: 1006–1018.
Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II et al. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor gamma2 expression. Mol Cell Biol 2011; 31: 4270–4285.
Magudia K, Lahoz A, Hall A . K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc. J Cell Biol 2012; 198: 185–194.
Shin S, Dimitri CA, Yoon SO, Dowdle W, Blenis J . ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 2010; 38: 114–127.
Whitsett JA, Glasser SW . Regulation of surfactant protein gene transcription. Biochim Biophys Acta 1998; 19: 2–3.
Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama M et al. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Int J Cancer 2001; 91: 433–437.
Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 2002; 30: 151–157.
Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008; 27: 3635–3640.
Whitsett JA, Wert SE, Weaver TE . Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Ann Rev Med 2010; 61: 105–119.
Ihara Y, Kihara Y, Hamano F, Yanagida K, Morishita Y, Kunita A et al. The G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) facilitates tumor development by serving as an extracellular pH sensor. Proc Natl Acad Sci USA 2010; 107: 17309–17314.
Zhou Y, Rideout WM III, Zi T, Bressel A, Reddypalli S, Rancourt R et al. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nat Biotechnol 2010; 28: 71–78.
Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P et al. Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol 2011; 31: 1565–1576.
Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV et al. FOXM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 2008; 283: 20770–20778.
Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009; 462: 104–107.
Wang IC, Zhang Y, Snyder J, Sutherland MJ, Burhans MS, Shannon JM et al. Increased expression of FoxM1 transcription factor in respiratory epithelium inhibits lung sacculation and causes Clara cell hyperplasia. Dev Biol 2010; 347: 301–314.
Acknowledgements
We thank Ron Pratt for technical support with microCT imaging and Craig Bolte for helpful comments. This work was supported by NIH grants HL84151 (VVK) and CA142724 (TVK), the Career Development Award from National Lung Cancer Partnership (I-CW), research grants from National Science Council of Taiwan 102B0023V8 (I-CW) and Toward World-Class University Project of National Tsing Hua University 102N2052E1 (I-CW).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Wang, IC., Ustiyan, V., Zhang, Y. et al. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D. Oncogene 33, 5391–5396 (2014). https://doi.org/10.1038/onc.2013.475
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.475
Keywords
This article is cited by
-
The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1
Cell & Bioscience (2023)
-
Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1
Cell Death & Disease (2023)
-
The role of FoxM1 in immune cells
Clinical and Experimental Medicine (2023)
-
The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers
Oncogene (2021)
-
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
Oncogene (2021)